These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


470 related items for PubMed ID: 20609140

  • 1. Guidelines for the management of tinea capitis in children.
    Kakourou T, Uksal U, European Society for Pediatric Dermatology.
    Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Systemic antifungal therapy for tinea capitis in children.
    Chen X, Jiang X, Yang M, González U, Lin X, Hua X, Xue S, Zhang M, Bennett C.
    Cochrane Database Syst Rev; 2016 May 12; 2016(5):CD004685. PubMed ID: 27169520
    [Abstract] [Full Text] [Related]

  • 4. Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis.
    Grover C, Arora P, Manchanda V.
    Int J Dermatol; 2012 Apr 12; 51(4):455-8. PubMed ID: 22435438
    [Abstract] [Full Text] [Related]

  • 5. The assessment and management of tinea capitis in children.
    Ali S, Graham TA, Forgie SE.
    Pediatr Emerg Care; 2007 Sep 12; 23(9):662-5; quiz 666-8. PubMed ID: 17876261
    [Abstract] [Full Text] [Related]

  • 6. Systemic antifungal therapy for tinea capitis in children.
    González U, Seaton T, Bergus G, Jacobson J, Martínez-Monzón C.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD004685. PubMed ID: 17943825
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, Aboobaker J, Summerbell RC.
    Pediatr Dermatol; 2001 Oct 17; 18(5):433-8. PubMed ID: 11737692
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
    Rademaker M, Havill S.
    N Z Med J; 1998 Feb 27; 111(1060):55-7. PubMed ID: 9539918
    [Abstract] [Full Text] [Related]

  • 10. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST, Cucé LC, Foss NT, Marques SA, Santamaria JR.
    J Eur Acad Dermatol Venereol; 1998 Sep 27; 11(2):141-6. PubMed ID: 9784040
    [Abstract] [Full Text] [Related]

  • 11. Tinea capitis caused by Microsporum canis treated with terbinafine.
    Aste N, Pau M.
    Mycoses; 2004 Oct 27; 47(9-10):428-30. PubMed ID: 15504128
    [Abstract] [Full Text] [Related]

  • 12. New treatments for tinea capitis.
    Chan YC, Friedlander SF.
    Curr Opin Infect Dis; 2004 Apr 27; 17(2):97-103. PubMed ID: 15021047
    [Abstract] [Full Text] [Related]

  • 13. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
    Fleece D, Gaughan JP, Aronoff SC.
    Pediatrics; 2004 Nov 27; 114(5):1312-5. PubMed ID: 15520113
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
    Dastghaib L, Azizzadeh M, Jafari P.
    J Dermatolog Treat; 2005 Feb 27; 16(1):43-6. PubMed ID: 15897167
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J, Skerlev M, Orofino-Costa R, Zaitz VC, Horvath A, Chouela E, Romero G, Gourmala N, Paul C, Tinea Capitis Study Group.
    Br J Dermatol; 2002 May 27; 146(5):816-23. PubMed ID: 12000378
    [Abstract] [Full Text] [Related]

  • 16. Tinea capitis: a treatment update.
    Roberts BJ, Friedlander SF.
    Pediatr Ann; 2005 Mar 27; 34(3):191-200. PubMed ID: 15792111
    [Abstract] [Full Text] [Related]

  • 17. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D, Coley M, Silverberg JI, Alexis A, Silverberg NB.
    J Drugs Dermatol; 2012 Jul 27; 11(7):852-6. PubMed ID: 22777228
    [Abstract] [Full Text] [Related]

  • 18. Tinea capitis.
    Alvarez MS, Silverberg NB.
    Cutis; 2006 Sep 27; 78(3):189-96. PubMed ID: 17036663
    [Abstract] [Full Text] [Related]

  • 19. Clinical inquiries. What is the best oral antifungal medication for tinea capitis?
    Johnston KL, Chambliss ML, DeSpain J.
    J Fam Pract; 2001 Mar 27; 50(3):206-7. PubMed ID: 11252205
    [No Abstract] [Full Text] [Related]

  • 20. Tinea capitis.
    Gupta AK, Summerbell RC.
    Med Mycol; 2000 Aug 27; 38(4):255-87. PubMed ID: 10975696
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.